Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Inventory (2016 - 2025)

Historic Inventory for Pharma (IGC) over the last 16 years, with Q3 2025 value amounting to $658000.0.

  • Pharma's Inventory fell 5642.38% to $658000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $658000.0, marking a year-over-year decrease of 5642.38%. This contributed to the annual value of $1.4 million for FY2025, which is 1168.83% down from last year.
  • Pharma's Inventory amounted to $658000.0 in Q3 2025, which was down 5642.38% from $1.3 million recorded in Q2 2025.
  • In the past 5 years, Pharma's Inventory registered a high of $5.5 million during Q3 2021, and its lowest value of $658000.0 during Q3 2025.
  • Its 5-year average for Inventory is $2.9 million, with a median of $2.6 million in 2023.
  • In the last 5 years, Pharma's Inventory skyrocketed by 2904.59% in 2021 and then tumbled by 5642.38% in 2025.
  • Quarter analysis of 5 years shows Pharma's Inventory stood at $5.4 million in 2021, then plummeted by 30.95% to $3.7 million in 2022, then crashed by 48.64% to $1.9 million in 2023, then fell by 25.56% to $1.4 million in 2024, then tumbled by 54.08% to $658000.0 in 2025.
  • Its Inventory stands at $658000.0 for Q3 2025, versus $1.3 million for Q2 2025 and $1.4 million for Q1 2025.